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Abstract
Objectives: We reviewed our surgery registry, to identify predictive risk factors for operative results, and to analyse the long-term survival
outcome in octogenarians operated for primary isolated aortic valve replacement (AVR). Methods: A total of 124 consecutive octogenarians
underwent open AVR from January 1990 to December 2005. Combined procedures and redo surgery were excluded. Selected variables were
studied as risk factors for hospital mortality and early neurological events. A follow-up (FU; mean FU time: 77 months) was obtained (90%
complete), and Kaplan—Meier plots were used to determine survival rates. Results: The mean age was 82  2.2 (range: 80—90 years; 63%
females). Of the group, four patients (3%) required urgent procedures, 10 (8%) had a previous myocardial infarction, six (5%) had a previous
coronary angioplasty and stenting, 13 patients (10%) suffered from angina and 59 (48%) were in the New York Heart Association (NYHA) class III—IV.
We identified 114 (92%) degenerative stenosis, six (5%) post-rheumatic stenosis and four (3%) active endocarditis. The predicted mortality
calculated by logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) was 12.6  5.7%, and the observed hospital mortality
was 5.6%. Causes of death included severe cardiac failure (four patients), multi-organ failure (two) and sepsis (one). Complications were
transitory neurological events in three patients (2%), short-term haemodialysis in three (2%), atrial fibrillation in 60 (48%) and six patients were re-
operated for bleeding. Atrio-ventricular block, myocardial infarction or permanent stroke was not detected. The age at surgery and the
postoperative renal failurewere predictors for hospitalmortality ( p value<0.05), whereas we did not find predictors for neurological events. The
mean FU time was 77 months (6.5 years) and the mean age of surviving patients was 87  4 years (81—95 years). The actuarial survival estimates
at 5 and 10 years were 88% and 50%, respectively. Conclusions:Our experience shows good short-term results after primary isolated standard AVR
in patients more than 80 years of age. The FU suggests that aortic valve surgery in octogenarians guarantees satisfactory long-term survival rates
and a good quality of life, free from cardiac re-operations. In the era of catheter-based aortic valve implantation, open-heart surgery for AVR
remains the standard of care for healthy octogenarians.
# 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Over the past 20 years, the life expectancy for men and
women has extended continuously in developed countries
and it is increasing constantly for people reaching the age of
80, as confirmed by the latest registry reports brought out by
Western countries: it is above 7 years and 10 years for men
and women, respectively. Because of this rapid ageing
population, cardiovascular diseases are one of the most
important causes of poor quality of life in the elderly, and a
relevant cause of death. Consequently, the number of
octogenarians referred to heart surgery has also rapidly
increased, and it will probably continue to increase in future.
In our demographic population, octogenarians showing signs* Corresponding author. Address: Department of Cardiovascular Surgery,
Centre Hospitalier Universitaire Vaudois (CHUV), 46, rue du Bugnon, CH-
1011 Lausanne, Switzerland. Tel.: +41 79 310 1386; fax: +41 21 314 2278.
E-mail address: enricoferrari@bluewin.ch (E. Ferrari).
1010-7940/$ — see front matter # 2010 European Association for Cardio-Thoracic S
doi:10.1016/j.ejcts.2010.01.049of degenerative aortic valve stenosis (AS) are increasingly
common (disease prevalence of >20%), with consequently
a greater amount of increasingly older patients requiring
aortic valve replacement (AVR) [1]. This phenomenon
seems to be clearly promoted by the ameliorated quality
of life, the longest life expectancy and the overall good
health conditions of this sub-population. Moreover, previous
reports have demonstrated that important results obtained
after a standard AVR (low operative mortality/morbidity rate
and improved quality of life) are also achievable by this
subgroup of very old patients, according to an overall
amelioration in early- and late-outcomes after AVR in the
elderly [2—7]. This retrospective clinical report aims to
discuss our single-centre experience with octogenarians who
underwent primary, isolated standard AVR in our cardiovas-
cular surgery unit over a period of 16 years (January 1990—
December 2005). Short- and long-term survival outcomes are
outlined, and an analysis of risk factors for in-hospital
mortality and early neurological events is provided.urgery. Published by Elsevier B.V. All rights reserved.
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Fig. 1. The graphic shows the distribution, annually, of octogenarians oper-
ated in our institution for primary, isolated aortic valve replacement during a
period of sixteen years (January 1990—December 2005), and the related
hospital mortality.2. Materials and methods
We retrospectively analysed our digital surgery registry to
identify patients more than 80 years of age, who underwent
primary, isolated standard AVR in our cardiovascular surgery
unit, between January 1990 and December 2005 (16 years of
activity). Patients undergoing redo surgery or AVR combined
with coronary artery bypass grafting, or patients who were
operated for combined aortic and mitral valve replacement/
repair, were excluded from our study. Preoperative and
postoperative data taken from the clinical dossiers were
collected and retrospectively analysed. Furthermore, a long-
term follow-up (FU; mean FU time: 77 months) was obtained
contacting the patients themselves (wherever possible), a
member of their family or their general practitioner.
2.1. Statistical analysis
The statistical analysis was performed using the SPSS 15.0
statistical software package for Windows (SPSS Inc., Chicago,
IL, USA). Continuous variables are summarised as mean  1
standard deviation (SD). Categorical variables are presented
as numbers and proportions (%). Selected categorical and
continuous preoperative and postoperative variables were
analysed as risk factors for hospital mortality (defined as any
death occurring within 30 days of the operation or death
during the same hospital admission) or early neurological
complications, using the Fisher’s exact test or the Wilcoxon
signed-rank test. A p-value less than 0.05 was considered to
be statistically significant. The estimate survival curves were
computed with the Kaplan—Meier method (a log-rank test
was also performed to compare the men’s and the women’s
survival curves).
Authors had full access to data and they take responsibility
for their integrity.
2.2. Surgical procedures
All patients underwent AVR for following our standard
surgical protocol (open-heart surgery). A preoperative
Doppler evaluation of the carotid arteries was introduced
routinely since 2000: in case of presence of a severe left
carotid artery disease, a surgical thrombo-endarterectomy
under local anaesthesia was scheduled separately, before the
AVR. A preoperative computed tomography (CT) scan to
evaluate the quality of the ascending aorta has never
been performed routinely in our institution. The anaesthe-
siological management for these patients underwent few
modifications during this period of time. Through a median
sternotomy, a standard cannulation was performed in the
routine fashion, and, since 2005, we routinely employed the
Embol-XTM arterial cannula (Edwards Lifesciences, Irvine, CA,
USA) to prevent calcium migration. After having clamped the
aorta and arrested the heart with antegrade/retrograde cold
blood cardioplegia or cold crystalloid cardioplegia solution
(St. Thomas) added to topical cooling, the ascending aorta
was opened and the aortic valve was replaced with a
bioprosthesis (only biological prosthesis were used because
of patients’ mean age) fixed to the aortic annulus (intra-
annular or supra-annular) using either six 2/0 polypropylene
running sutures [8] or multiple 2/0 U-fashion single stitchesreinforced with pledgets. An intra-operative two-dimen-
sional trans-oesophageal echocardiogram (TEE) was per-
formed routinely. The postoperative full anticoagulation
therapy included 3 months of warfarin or Coumadin
(international normalised ratio (INR) of 2.5—3.5%), in the
absence of permanent atrial fibrillation or other concomitant
co-morbidities requiring long-lasting anticoagulation.
3. Results
Between January 1990 and December 2005, 124 con-
secutive octogenarians underwent open AVR in our hospital
(Fig. 1). Four cases (3%) required an urgent procedure
(endocarditis). The mean age was 82  2.2 (range: 80—90
years) and 63% were female. Regarding the risk factors and
previous cardiac events, 71 patients (57%) suffered from
hypertension, 27 (22%) showed signs of chronic renal
insufficiency (serum creatinine level above 150 mg dl1),
29 (23%) were affected by hypercholesterolaemia and 13 by
diabetes (three patients (2%) by diabetes type I and 10 (8%) by
diabetes type II). Thirteen patients (10%) were suffering from
stable angina and 20 (16%) had a positive anamnesis of
coronary artery disease: in particular, 10 patients (8%) had
previously had an acute myocardial infarction, and, of these,
six (5%) were treated by coronary angioplasty (PTCA) and
coronary stent positioning. Seven patients (6%) were already
equipped with a pacemaker. Among the 124 octogenarians,
59 (48%) were chronically symptomatic for severe dyspnoea
(the New York Heart Association (NYHA) functional class III
and IV). Preoperative details are listed in Table 1.
The preoperative transthoracic echocardiogram (TTE)
showed 60% of patients had good left ventricular function
(left ventricle ejection fraction (LVEF): above 50%), 32%
with moderate left ventricular function (LVEF: between 30%
and 50%) and 8% with poor left ventricular function (LVEF:
below 30%). As far as the aetiology of valve disease and
haemodynamic parameters are concerned, the age-related
degenerative AS was the most common disease, with 114 out
of 124 patients (92%) affected (old sub-population). Less
frequently, patients were affected by post-rheumatic aortic
valve degeneration (5%), and acute or sub-acute aortic valve
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Table 1
Demographics, symptoms, and risk factors.
N (%) p for hospital
mortality
No. of patients 124 —
Age (years) 82  2.2 (range 80—90) 0.043
Women 78 (63%) NS
Mean logistic EuroSCORE (%) 12.6  5.7 —
Dyspnoea (NYHA functional class):
I 10 NS
II 55 (44%)
III 38 (31%)
IV 21 (17%)
Angina 13 (10%) NS
Associate coronary disease 20 (16%) 0.083
Previous myocardial infarction 10 (8%) NS
Previous PTCA/coronary stenting 6 (5%) NS
Hypertension 71 (57%) NS
Renal insufficiency 27 (22%) NS
Diabetes type 1 3 (2%) NS
Diabetes type 2 10 (8%) 0.099
Hypercholesterolemia 29 (23%) NS
Data are presented as mean  SD or N (%). NYHA: New York Heart Association;
PTCA: percutaneous coronary angioplasty.
Table 3
Implanted biological prosthesis (N: 124 patients).
Edwards Lifesciences PerimountTM, MagnaTM, Magna EaseTM 88 (71%)
St. Jude BiocorTM 12 (10%)
Shellhigh stentless bioprosthesis 11 (9%)
Sorin Group MitroflowTM 9 (7%)
Medtronic FreestyleTM 4 (3%)
Mean valve size (mm) 23  2
Size distribution:
19 mm 3 (2%)
21 mm 39 (32%)
23 mm 44 (36%)
25 mm 29 (23%)
27 mm 7 (6%)
29 mm 2 (1%)
Data are presented as mean  SD or N (%).
Table 4
Operative results (N: 124 patients).
N (%) p for hospital
mortalityendocarditis (3%). Regarding the valve haemodynamic, 107
(86%) were pure stenosis, six patients (5%) carried a pure
regurgitation and 11 (9%) had a combination of stenosis and
regurgitation (Table 2).
The predicted hospital mortality calculated by logistic
European System for Cardiac Operative Risk Evaluation
(EuroSCORE; www.euroscore.org) was 12.6  5.7%.
All 124 patients were successfully operated for AVR and 18
procedures (14%) also required a combined sub-valvular
septal myectomy. The implanted valves were all biological
prosthesis (100%), according to the patients’ mean age: the
mean valve size was 23  2 mm, and the different types of
implanted bioprosthesis are listed in Table 3. Mean
cardiopulmonary bypass time and aortic cross-clamp time
were 80  18 min and 58  14 min, respectively, and the
mean operative time was 138  28 min. The observed
hospital mortality was 5.6% (seven patients). Among theTable 2
Preoperative 2D echocardiogram assessment and valve disease.
N (%) p for
hospital
mortality
Left ventricle ejection fraction — LVEF (%)
>50% 60% NS
30—50% 32% NS
<30% 8% 0.066
Mean aortic valve area (cm2) (stenosis) 0.6  0.1 —
Mean trans-valvular peak
gradient (mmHg) (stenosis)
76.6  21.2 —
Pure aortic valve stenosis 107 (86%) —
Pure aortic valve regurgitation 6 (5%) —
Combined valve stenosis and regurgitation 11 (9%) —
Degenerative aortic valve disease 114 (92%) —
Post rheumatic aortic valve disease 6 (5%) —
Endocarditis (acute/sub-acute) 4 (3%) —
Data are presented as mean  SD or N (%).seven patients who died during postoperative recovery in the
intensive care unit (ICU), four died of severe postoperative
cardiac failure, two died of multi-organ failure (MOF) and one
patient of sepsis.
Concerning early postoperative complications (listed in
Table 4), the intra-aortic balloon pump (IABP) was used three
times intra-operatively (2%), a re-thoracotomy for bleeding
was necessary six times (5%) and a transitory acute renal
failure occurred 14 times (12%). Eleven patients with
postoperative renal insufficiency required a conservative
medical treatment, while a short treatment with continuous
dialysis was necessary for three patients (2%). Of the entire
group, three patients (2%) showed signs of transitory
neurological events: one right hemiplegia regressing after
5 h, one visual trouble (amaurosis) and a one Wernike’s
aphasia. All these neurological complications regressed
spontaneously without medical treatments during the post-
operative recovery, and all 117 patients who survived surgery
were discharged from our hospital without signs of stroke.
The mean hospital and ICU stay were 15  6 and 4  2 days,Hospital mortality 7 (6%) —
Causes of death:
Severe cardiac failure 4
MOF 2
Sepsis 1
Atrial fibrillation 60 (48%) NS
Acute renal failure 14 (11%) 0.001
Dialysis (transitory) 3 (2%)
Surgical bleeding requiring re-thoracotomy 6 (5%) NS
Pneumonia 11 (9%) NS
Cardiac dysfunction: 7 (6%) NS
Severe 4
Mild 3
Intra-operative IABP 3 (2%) NS
Mediastinitis 1 (1%) NS
Sepsis 1 (1%) NS
Transitory neurological events 3 (2%) NS
Data are presented as mean  SD or N (%). MOF: multi-organ failure; IABP:
intra-aortic balloon pump.
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Table 5
Follow-up (117 patients survived at surgery; N:105 patients contacted success-
fully at FU).
Mean FU time (months) 77 (6.5 years)
FU completeness 105/117 patients (90%)
Missing patients at FU 12/117 (10%)
Patients alive at FU 67/105 (64%)
Mean age of surviving patients (years) 87.1  3.7 (range 81—95)
Mortality during the FU 38/105 (32%)
Estimated prosthesis dysfunctions 0
Valve-related cardiac re-operations 0
Dyspnoea (NYHA class):
I 59
II 8
III 0
IV 0
Causes of death:
Cardiac 7
Stroke 5
Cancer 5
Renal failure 2
Traumas 3
Unknown 16
Data are presented as mean  SD or N (%). FU: follow-up.
Fig. 3. Cumulative Kaplan—Meier survival curves, for males/females sepa-
rately.respectively, and three patients required a prolonged
hospital stay (>20 days).
Data from the long FU were systematically analysed and
listed in Table 5. The mean FU time was 77 months and the
mean age of people still alive at FU was 87  4 years (67/105
patients, range: 81—95 years). Despite difficulties in
collecting information regarding octogenarians operated
during the 90 s, for 90% of patients (105/117), complete
FU has been obtained. Nevertheless, data coming from this
survey are interesting: the Kaplan—Meier curves (Figs. 2 and
3) show that the actuarial survival estimates for our selected
cohort of patients are 88% at 5 years and 50% at 10 years.
Thirty-eight patients died during the FU: among the causes of
death, a cardiac cause was counted seven times (which were
mostly ischaemic events), a stroke five times and in 16 cases
the cause of death was not identified. However, we could
not prove any valve-related death and any valve-related
complication (bleeding or endocarditis), or prosthesis
dysfunction, and there were no cardiac re-operations.
Patients answering at FU (67) were doing well and, in the
course of the interview, they confirmed a fulfilling quality of
life comparable to the standard quality of life of non-Fig. 2. Cumulative Kaplan—Meier survival curves.operated octogenarians. With regard to the presence of
cardiac symptoms, no patient described angina, 59 were in
NYHA functional class I, and eight were in NYHA functional
class II.
4. Discussion
In the era of catheter-based stent-valve implantation
(transfemoral and trans-apical procedures), open-heart
surgery remains the gold standard for primary, isolated
AVR. Nevertheless, cardiologists and cardiac surgeons in
developed countries are increasingly faced with having to
treat a population aged 80 years or more, suffering from
severe and symptomatic AS, and requiring medical or surgical
treatment. The natural prognosis of severe AS becoming
symptomatic is well known: 90% of patients die within 3 years
of the onset of symptoms (typically angina, syncope and
dyspnoea) and, if heart failure is present, death occurs within
2 years [9—11]. Unfortunately, the advancing age of these
patients together with their concomitant co-morbidities, are
perceived by the general practitioner and/or cardiologists as
important risk factors for poor outcomes once surgical AVR
and clinicians are encouraged to investigate non-surgical
options. However, the non-surgical options are affected by a
very poor outcome: solely medical management is associated
with high mortality within 3 years, and balloon valvuloplasty
is associated with short-term re-stenosis and a high necessity
for re-intervention [12,13].
Therefore, non-traditional techniques should be com-
pared with modern short- and long-term outcomes of
standard open AVR in octogenarians. Our report confirms
that primary, isolated standard AVR can be performed safely
in this subgroup of patients, with acceptable morbidity and
hospital mortality. In our series, the 30-day mortality (5.6%)
and the incidence of major postoperative complications
compare favourably to data present in literature and data
reported in other series [2—6]. Despite earlier reports (early
to mid-1990s) of isolated AVR in the elderly, which showed
higher operative mortality (from 6% to 20%), recent articles
have shown a lower mortality rate ranging around 3—10%:
Thourani et al. [6], for example, described 88 octogenarians
operated for isolated AVR with a hospital mortality of 5.7%;
Kolh et al. [5] reported a 30-day mortality of 8.5% in a series
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reported by Chiappini et al. [14] who described a mortality
rate of 8.5% in a group of octogenarians requiring isolated and
combined AVR, and by Collart et al. [15] who described a
short-term mortality of 8.8% in a cohort of 215 elderly
patients requiring valve replacements. The reason for such a
decline in hospital mortality is probably multifactorial.
Nevertheless, the ameliorations in surgical techniques,
cardiac anaesthesia and intensive care postoperative man-
agement certainly play a key role in decreasing the operative
mortality risk and the onset of postoperative complications.
In our group of patients, the predictive hospital mortality
calculated by logistic EuroSCORE was 12.6%, a value almost
twice the observed mortality rate (5.6%). Following the
latest trend of using the EuroSCORE system to identify high-
risk AVR patients to be addressed for trans-catheter therapies
(EuroSCORE >20%), our data confirm that the logistic
EuroSCORE remains a useful tool, despite the fact that the
predicted operative mortality is overestimated and needs to
be halved, in general, to coincide with the real score [16].
Another aspect that must be underlined is the incidence of
postoperative complications. In general, one of the most
important aspects after an AVR procedure is the patient’s
quality of life and the absence of irreversible complications:
in particular, as far as octogenarians are concerned, the onset
of major neurological complications can determine a total
change in their quality of life, with serious changes in
physical well-being and mental state [7,17,18]. Neurological
complications can lead to severe handicaps with loss of
independence and physical autonomy. In our cohort, we
experienced three cases (2%) of transitory neurological
events before the advent of the Embol-XTM arterial cannula
(in 2005): symptoms regressed spontaneously within few
hours, with no patients leaving our institution with signs of
stroke. This result is in line with rates reported in other
series: Thourani et al. [6] showed 3.4% of neurological events
in his cohort of elderly patients, whereas Kolh et al. [5]
reported a stroke rate of 2.8%. Nevertheless, despite the
evidence of a decreasing trend in stroke after AVRs, the risk
of calcium migration from the valve itself, from the
cannulation site or from the aortic cross-clamping site
remains relevant, and all efforts should be undertaken to
decrease this risk constantly (new-generation arterial
cannulas, routine epi-aortic ultrasound and preoperative
CT-scan imaging).
Regarding the operative morbidity, the incidence of renal
insufficiency, re-operation for bleeding, pneumonia and
atrial fibrillation is compatible with other recent reports
[3—7].
We also tried to define risk factors for early death and
early neurological events: the age at surgery and the income
of postoperative renal failure were the only preoperative risk
factors statistically associated with higher operative mor-
tality ( p value <0.05). Risk factors for early neurological
events were not identified, whereas the presence of
concomitant coronary disease, an impaired left ventricular
function and type II diabetes were also associated with higher
hospital mortality despite a lower statistical significance.
With regard to the long-term outcome and quality of life,
our survival estimates at 5 and 10 years were 88% and 50%,
respectively, showing good long-term results despite theadvanced age. The 5-year survival estimate, in particular,
appears higher than the one expected in AVR in octogenarians,
which is around 50—70% [19], and it appears also higher than
the 5-year rates of 55% [20], 69.4% [14], 56% [4] and 61% [6],
recently published in comparable series. On the other hand,
the survival estimates for our sub-population are lower than in
younger patients, but they compare favourably with the life
expectancyof a general population of octogenarians; anda 10-
year survival rate of 50% appears extremely favourable.
Moreover, these patients do not only have a longer expectancy
of life, but they also enjoy an improved quality of life. Patients
aliveat FUweredoing surprisinglywell,witha highpercentage
of people still living at home orwith their families. Concerning
valve-related complications, no thrombo-embolic events,
bleedings, endocarditis, structural failure or re-operations
were clearly identified at FU. Nevertheless, valve-related
complications cannot be totally excluded from the following
series because in many cases the cause of death was unclear:
16 patients died for unknown reasons, seven patients died
during FU from the evolution of their undefined heart disease
(probably ischaemic, arrhythmic or valvular) and in five cases
there were occurrences of stroke.
The current study has some important limits as its single-
centre retrospective nature and the possibility of bias
present in the selection criteria. It is not inadmissible that
patients ‘too sick for surgery’ were excluded following
personal selection criteria of the individual cardiologist or
surgeon, and such criteria probably changed continuously
over a period of 16 years. However, the study confirms the
reliability of standard open AVR in very old patients during a
lapse of time of 16 years.
In conclusion, conventional primary, isolated AVR can be
safely performed in octogenarians with acceptable mortality,
good long-term survival and good quality of life. Patients of
80 years of age or older carrying a mid- or low-operative risk
should not be denied the benefit of standard surgery that
remains, so far, the standard of care for isolated AVR. As an
alternative, elderly high-risk patients should become candi-
dates for trans-catheter AVR therapies, and it is plausible
that, in a near future, percutaneous procedures may provide
evident benefits in terms of postoperative mortality and
morbidity.
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